AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,162,533 | +42.7% | 18,796 | +6.1% | 0.53% | +32.7% |
| Q3 2023 | $814,529 | -11.0% | 17,711 | +11.3% | 0.40% | -7.0% |
| Q2 2023 | $914,693 | +13.7% | 15,916 | -25.8% | 0.43% | +8.1% |
| Q1 2023 | $804,488 | +133.3% | 21,453 | +74.3% | 0.40% | +141.5% |
| Q4 2022 | $344,786 | +0.5% | 12,305 | +0.8% | 0.16% | -4.1% |
| Q3 2022 | $343,000 | +69.0% | 12,208 | +109.4% | 0.17% | +71.0% |
| Q2 2022 | $203,000 | – | 5,829 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 130,250 | $4,884,375 | 4.79% |
| SHAKER INVESTMENTS LLC/OH | 82,253 | $3,084,488 | 1.72% |
| Mesirow Institutional Investment Management, Inc. | 325,669 | $12,212,588 | 1.33% |
| Portolan Capital Management | 340,593 | $12,772,238 | 1.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 178,200 | $6,682,500 | 1.04% |
| Granite Investment Partners, LLC | 536,821 | $20,130,788 | 0.84% |
| Capital Impact Advisors, LLC | 15,304 | $573,900 | 0.70% |
| Hillsdale Investment Management Inc. | 155,038 | $5,813,926 | 0.50% |
| GLOBEFLEX CAPITAL L P | 89,192 | $3,344,700 | 0.41% |
| Jackson Creek Investment Advisors LLC | 25,877 | $970 | 0.41% |